News Results
There are 165,909 News Results
Nov 5, 2018
THOUSAND OAKS, Calif., Nov. 5, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the presentation of 10 scientific research abstracts, including the final report of the OSLER-1 study, evaluating the long-term...
Nov 5, 2018
MONROVIA, Calif., Nov. 5, 2018 /PRNewswire/ -- Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune disease, asthma and allergic diseases, and cancer,...
Nov 5, 2018
ALAMEDA, Calif., Nov. 5, 2018 /PRNewswire/ -- Penumbra, Inc.
Nov 6, 2018
Revenue of $126.7 million Operating income of $3.7 million Adjusted EBITDA (see table 1 below) of $13.7 million or 10.8% of revenue Contract awards of $312 million Company revises its...
Nov 7, 2018
BWX Technologies, Inc. (NYSE: BWXT) (“BWXT,” “we,” “us” or the “Company”) reported third quarter 2018 revenue of $426 million, a 1.5% increase compared to $419 million in the third quarter...
Nov 6, 2018
NEW YORK, Nov. 6, 2018 /PRNewswire/ -- Genpact Limited (NYSE: G), a global professional services firm focused on delivering digital transformation, today announced financial results for the third quarter ended...
Nov 6, 2018
SOUTH SAN FRANCISCO, Calif., Nov. 6, 2018 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL), today reported financial results for the third quarter ended September 30, 2018, and also provided an update...
Nov 6, 2018
HAYWARD, Calif., Nov. 6, 2018 /PRNewswire/ -- Ultra Clean Holdings, Inc. (Nasdaq: UCTT), a leading developer and supplier of critical subsystems, ultra-high purity cleaning and analytical services for the semiconductor...
Nov 6, 2018
SANTA CLARA, Calif., Nov. 6, 2018 /PRNewswire/ -- Coherent, Inc. (NASDAQ, COHR), one of the world's leading providers of lasers, laser-based technologies and laser-based system solutions in a broad range...
Nov 6, 2018
Theravance Biopharma, Inc. Reports Third Quarter 2018 Financial Results and Provides Business Update
DUBLIN, Nov. 6, 2018 /PRNewswire/ -- Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today reported financial results for the third quarter ended September 30, 2018. Revenue for...